Poolbeg Pharma PLC Ordinary Shares (POLB)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
3.70p
Buy
4.20p
0.10p (+2.60%)
Prices updated at 17 Dec 2025, 13:54 GMT
| Prices minimum 15 mins delay
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
No data available
Valuation
No data available
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
Price/Forward earnings (YTD)
-3.50
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -45.10 |
| 2023 | -22.65 |
| 2022 | -22.15 |
| 2021 | -10.15 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.11 |
| 2023 | 1.07 |
| 2022 | 1.05 |
| 2021 | 1.02 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.